H.R. 843
This bill authorizes the Food and Drug Administration (FDA) to approve certain applications to market a generic drug despite the omission of certain safety information from the generic drug's labeling.
Learn about this bill’s status and read its full summary in the Pocket Congress app.
Scan to open this page in Pocket Congress